Literature DB >> 17827968

Contribution of hematocrit to early mortality after ischemic stroke.

Simona Sacco1, Carmine Marini, Luigi Olivieri, Francesca Pistoia, Antonio Carolei.   

Abstract

BACKGROUND: Only a few non-recent studies assessed the importance of hematocrit (HCT) in patients with ischemic stroke. We evaluated how HCT might affect early mortality after stroke.
METHODS: We investigated all first-ever ischemic strokes included in the population-based L'Aquila registry. 3,481 patients according to HCT (%) values were included into four categories (<or=40, 41-45, 46-50, and >50).
RESULTS: There were more men than women with HCT >50 (6.6 vs. 2.8%; p < 0.0001) and more women than men with HCT <or=40 (48.5 vs. 37.9%; p < 0.0001). Proportions of chronic atrial fibrillation (p = 0.0053) increased in women from the lower to the higher HCT categories. 7- and 28-day case-fatality rates were similar in men and women in the lower HCT categories but higher in women than in men in the higher categories. At the 28-day Kaplan-Meier analysis, men had similar survivals in the different categories while women with HCT >50 showed the worst survival (p < 0.0001). At the multivariate Cox regression analysis HCT 46-50 and >50 was an independent predictor of mortality in women within 28 days.
CONCLUSION: High HCT might represent in women a previously underestimated independent predictor of mortality after ischemic stroke. Consideration of HCT in future stroke trials would be useful for ameliorating stroke care, especially in women. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17827968     DOI: 10.1159/000107946

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  12 in total

1.  Quantitative electrocardiography for predicting postoperative atrial fibrillation after cardiac surgery.

Authors:  Florian Rader; Otto Costantini; Craig Jarrett; Eiran Z Gorodeski; Michael S Lauer; Eugene H Blackstone
Journal:  J Electrocardiol       Date:  2011-01-26       Impact factor: 1.438

2.  The Lombardia Stroke Unit Registry: 1-year experience of a web-based hospital stroke registry.

Authors:  Giuseppe Micieli; Anna Cavallini; Silvana Quaglini; Giancarlo Fontana; Michela Duè
Journal:  Neurol Sci       Date:  2010-03-26       Impact factor: 3.307

Review 3.  Red blood cell transfusion in the neurological ICU.

Authors:  Monisha A Kumar
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

4.  Evaluation of routinely performed hematological and biochemical parameters for the prognosis of acute ischemic stroke patients.

Authors:  Amit R Nayak; Rajpal S Kashyap; Dinesh Kabra; Prashant Deoras; Hemant J Purohit; Girdhar M Taori; Hatim F Daginawala
Journal:  Neurol Sci       Date:  2011-08-24       Impact factor: 3.307

5.  Anemia status, hemoglobin concentration and outcome after acute stroke: a cohort study.

Authors:  David Tanne; Noa Molshatzki; Oleg Merzeliak; Rakefet Tsabari; Maya Toashi; Yvonne Schwammenthal
Journal:  BMC Neurol       Date:  2010-04-09       Impact factor: 2.474

Review 6.  Mechanisms linking red blood cell disorders and cardiovascular diseases.

Authors:  Ioana Mozos
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

Review 7.  Anemia and red blood cell transfusion in neurocritical care.

Authors:  Andreas H Kramer; David A Zygun
Journal:  Crit Care       Date:  2009-06-11       Impact factor: 9.097

Review 8.  Monitoring of hematological and hemostatic parameters in neurocritical care patients.

Authors:  Andrew M Naidech; Monisha A Kumar
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

9.  Commentary: Why Your Body Can Jog Your Mind.

Authors:  Francesca Pistoia; Marco Sarà; Antonio Carolei; Simona Sacco
Journal:  Front Psychol       Date:  2018-02-08

10.  Association between admission haematocrit and mortality among men with acute ischaemic stroke.

Authors:  Jason J Sico; Laura J Myers; Brenda J Fenton; John Concato; Linda S Williams; Dawn M Bravata
Journal:  Stroke Vasc Neurol       Date:  2018-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.